SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular CarcinomaPierce K. H. Chow, Mihir Gandhi, Say‐Beng Tan et al.|Journal of Clinical Oncology|2018Cited by 653